Stocklytics Platform
Asset logo for symbol STOK
Stoke Therapeutics
STOK52
$8.60arrow_drop_up6.16%$0.50
Asset logo for symbol STOK
STOK52

$8.60

arrow_drop_up6.16%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Stoke Therapeutics (STOK) Stocklytics Forecast

Stoke Therapeutics Inc (STOK) is a biotechnology company focused on developing treatments for severe genetic diseases. The company utilizes an innovative approach called Targeted Augmentation of Nuclear Gene Output (TANGO) to address the underlying genetic cause of diseases. With the potential to create transformative therapies, Stoke Therapeutics has garnered significant attention from investors and analysts alike.
In terms of the STOK stock price forecast, many analysts have expressed optimism about the company's future prospects. The AI and machine learning algorithms used for price prediction have also generated positive signals. While it is important to note that these predictions are not guaranteed, they provide valuable insights into potential market trends.
add Stoke Therapeutics  to watchlist

Keep an eye on Stoke Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Stoke Therapeutics (STOK) stock?

Analysts have set a target price of $23.67 for Stoke Therapeutics (STOK), based on forecasts from 27 analysts. The predicted price range extends from a high of $35 to a low of $12. This represents a potential increase of up to 306.98% and a decrease of 39.53% from the current price of $8.6. These forecasts are as of 2023 Mar 07.
help

What are the analyst ratings for Stoke Therapeutics (STOK) stock?

The analyst ratings for Stoke Therapeutics (STOK) are distributed as follows: 9 analysts recommend buying, 1 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 10 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Stoke Therapeutics .
help

What is the AI price prediction for Stoke Therapeutics (STOK) stock?

At present, there is no AI or machine-learning-based price prediction available for Stoke Therapeutics (STOK) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level